EICHORPublic-registry site landscape for NCT05518149, “A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD)”, a Depressive Disorder, Major study sponsored by Janssen Research & Development, LLC. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT05518149 (registry record) |
| Study title | A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD) |
| Official title | An Open-label, Long-term, Safety and Efficacy Study of Aticaprant as Adjunctive Therapy in Adult and Elderly Participants With Major Depressive Disorder (MDD) |
| Sponsor | Janssen Research & Development, LLC |
| Condition(s) | Depressive Disorder, Major |
| Phase | PHASE3 |
| Listed sites | 234 |
| Site countries | United States, Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, Czechia, France, Hungary, Italy |
Patient-friendly overview of this study: eichor.com/study/NCT05518149.
Eichor generates a preliminary site-risk snapshot for NCT05518149 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
Other Depressive Disorder, Major trials
More from Janssen Research & Development, LLC
← Eichor home · All tracked trials · Depressive Disorder, Major studies · Weekly briefs
